QCM Cayman’s Tiziana Life Sciences TLSA Stock Holding History

QCM Cayman’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,298	Closed	-$29K	–	174
2021 Q1	$29K	Buy	+10,298	New	+$34.2K	0.09%	107

Other funds holding TLSA

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

CAAS

Capital Asset Advisory Services Williamston, Michigan $2.61B AUM 15.59% 1-Year Est. Return

QCM Cayman's TLSA Position: Q2 2021 in Review

QCM Cayman sold out of Tiziana Life Sciences (TLSA) in Q2 2021, closing a stake of 10,298 shares — an estimated $29K sold.

QCM Cayman first reported a position in TLSA in Q1 2021 and held it in 1 quarter. The position peaked at $29K in Q1 2021. 23 funds tracked by Wall St. Rank hold TLSA as of Q2 2021.

QCM Cayman reported no remaining Tiziana Life Sciences position as of Q2 2021 after selling out during the quarter.
QCM Cayman sold 10,298 Tiziana Life Sciences shares in Q2 2021, an estimated $29K.
QCM Cayman first reported a position in Tiziana Life Sciences in Q1 2021 and held it in 1 quarter.
QCM Cayman's Tiziana Life Sciences position peaked at $29K in Q1 2021.
23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2021.

Based on QCM Cayman's 13F filing for Q2 2021, filed 10 Aug 2021.